Paracentesis-induced circulatory disturbance (PICD) is a very common cause of mortality and morbidity in patients undergoing large-volume paracentesis. Albumin is commonly used in decompensated cirrhosis during large-volume paracentesis. However, it may not be cost-effective and has side effects like volume overload and transfusion reactions. Therefore the investigator proposed to use midodrine which is a drug that increases the mean arterial pressure. The investigators hypothesized that midodrine may be effective in preventing PICD in acute on chronic liver failure patients requiring modest paracentesis. This has already been found to be effective in initial studies in decompensated cirrhosis
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
50
Midodrine hydrochloride for PICD prevention
Human ALbumin 20% for prevention of paracentesis induced circulatory disturbance
Asian Institute of Gastroenterology
Hyderabad, Telangana, India
Prevention of Paracentesis induced circulatory disturbance
Measure the value of plasma renin activity on sixth day after paracentesis
Time frame: Day 6
Cost effectiveness of Midodrine versus Albumin
Cost effectiveness of use of Midodrine compared to Albumin
Time frame: Day 6
Hepatic Encephalopathy as measured by West-Haven criteria
Hepatic encephalopathy as measured by the West Haven criteria on day 6 in both midodrine and albumin groups
Time frame: Day 6
Renal outcome post paracentesis
Serum creatinine, serum sodium and serum potassium values on day 6 after paracentesis
Time frame: Day 6
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.